Company / EPS (Diluted)
NEKTAR THERAPEUTICS EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$8.68
FY2025
5-year range
-$8.68 / -$1.45
FY2021-FY2025
Trend
-498.6%
vs FY2024
Sector context
#196 of 204
Health Care
What the data says
EPS (Diluted) changed -499% YoY in FY2025, a notable deviation from the 9-year average annual change of -26%.
Based on SEC 10-K filings.
-8.68 in FY2025.
Declined from $-2.86 to $-8.68 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 204This company -$8.68 Sector average -$0.98
▼
-786.1% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 498.6% year-over-year.
- Ranks #196 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$8.68 | -498.6% |
| FY2024 | -$1.45 | +49.3% |
| FY2023 | -$2.86 | -14.9% |
| FY2022 | -$2.49 | +1.2% |
| FY2021 | -$2.52 | -166.7% |
| FY2020 | $3.78 | +709.7% |
| FY2019 | -$0.62 | +43.6% |
| FY2018 | -$1.10 | -161.9% |
| FY2017 | -$0.42 | -200.0% |
| FY2016 | -$0.14 | -156.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026